NO20013544D0 - Middel for å behandle Parkinsons sykdom samt anvendelse derav - Google Patents

Middel for å behandle Parkinsons sykdom samt anvendelse derav

Info

Publication number
NO20013544D0
NO20013544D0 NO20013544A NO20013544A NO20013544D0 NO 20013544 D0 NO20013544 D0 NO 20013544D0 NO 20013544 A NO20013544 A NO 20013544A NO 20013544 A NO20013544 A NO 20013544A NO 20013544 D0 NO20013544 D0 NO 20013544D0
Authority
NO
Norway
Prior art keywords
disease
treating parkinson
parkinson
improving agent
agent
Prior art date
Application number
NO20013544A
Other languages
English (en)
Other versions
NO20013544L (no
Inventor
Yasuto Itoyama
Hiroyuki Kato
Tsutomu Araki
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of NO20013544D0 publication Critical patent/NO20013544D0/no
Publication of NO20013544L publication Critical patent/NO20013544L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20013544A 2000-07-18 2001-07-17 Middel for å behandle Parkinsons sykdom samt anvendelse derav NO20013544L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000216763 2000-07-18

Publications (2)

Publication Number Publication Date
NO20013544D0 true NO20013544D0 (no) 2001-07-17
NO20013544L NO20013544L (no) 2002-01-21

Family

ID=18711968

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013544A NO20013544L (no) 2000-07-18 2001-07-17 Middel for å behandle Parkinsons sykdom samt anvendelse derav

Country Status (19)

Country Link
US (2) US7019032B2 (no)
EP (1) EP1174131B1 (no)
KR (1) KR100759771B1 (no)
CN (1) CN1179722C (no)
AT (1) ATE341318T1 (no)
AU (1) AU780328B2 (no)
BR (1) BR0102940A (no)
CA (1) CA2353205C (no)
DE (1) DE60123528T2 (no)
DK (1) DK1174131T3 (no)
ES (1) ES2272383T3 (no)
HU (1) HUP0102987A3 (no)
MX (1) MXPA01007210A (no)
NO (1) NO20013544L (no)
NZ (1) NZ513040A (no)
PT (1) PT1174131E (no)
RU (1) RU2275906C2 (no)
TW (1) TWI290831B (no)
ZA (1) ZA200105886B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100759771B1 (ko) * 2000-07-18 2007-10-04 오노 야꾸힝 고교 가부시키가이샤 성상세포 기능 개선제를 유효 성분으로 함유하는 파킨슨병치료제
US7928143B2 (en) 2003-10-03 2011-04-19 Ono Pharmaceutical Co., Ltd. Method for preventing and/or treating neurodegenerative diseases
EP1667672A4 (en) * 2003-10-03 2010-02-10 Ono Pharmaceutical Co METHOD FOR PREVENTING AND / OR TREATING NEURODEEGENERATIVE ILLNESSES
MXPA06003605A (es) * 2003-10-03 2006-06-14 Ono Pharmaceutical Co Preparacion de infusion que contiene acido (2r)-2-propiloctanoico como ingrediente activo.
BRPI0415001A (pt) * 2003-10-03 2006-11-07 Ono Pharmaceutical Co droga contendo ácido (2r)-2-propiloctanóico como o ingrediente ativo
US7820715B2 (en) 2004-04-28 2010-10-26 Ono Pharmaceutical Co., Ltd. Crystal comprising (2R)-2-propyloctanoic acid and amine
TW200613009A (en) * 2004-06-11 2006-05-01 Ono Pharmaceutical Co Capsule having chewing stability
US9517221B2 (en) 2006-03-09 2016-12-13 Ono Pharmaceutical Co., Ltd. (2R)-2-propyloctanoic acid for functional brain disease
WO2009102443A2 (en) * 2008-02-15 2009-08-20 The Government Of The Usa, As Represented By The Secretary Of The Dept. Of Health & Human Services; Octanoic acid formulations and methods of treatment using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU209564B (en) 1991-01-30 1994-07-28 Egyt Gyogyszervegyeszeti Gyar Process for producing rapide tablets containing levodopa and carbidopa
TW248552B (no) * 1993-06-01 1995-06-01 Onoda Yakuhin Kogyo Kk
US5672746A (en) 1994-08-30 1997-09-30 American Biogenetic Sciences, Inc. Antiproliferative and neurotrophic molecules
KR100759771B1 (ko) * 2000-07-18 2007-10-04 오노 야꾸힝 고교 가부시키가이샤 성상세포 기능 개선제를 유효 성분으로 함유하는 파킨슨병치료제

Also Published As

Publication number Publication date
TWI290831B (en) 2007-12-11
ES2272383T3 (es) 2007-05-01
NO20013544L (no) 2002-01-21
HUP0102987A2 (hu) 2002-04-29
DE60123528T2 (de) 2007-02-15
AU780328B2 (en) 2005-03-17
DK1174131T3 (da) 2007-02-05
CN1179722C (zh) 2004-12-15
HU0102987D0 (en) 2001-09-28
US20060052453A1 (en) 2006-03-09
ATE341318T1 (de) 2006-10-15
ZA200105886B (en) 2002-01-17
US20020032185A1 (en) 2002-03-14
US7019032B2 (en) 2006-03-28
NZ513040A (en) 2003-02-28
HUP0102987A3 (en) 2003-02-28
EP1174131B1 (en) 2006-10-04
CA2353205A1 (en) 2002-01-18
PT1174131E (pt) 2007-01-31
MXPA01007210A (es) 2004-10-29
CN1334081A (zh) 2002-02-06
CA2353205C (en) 2008-10-07
RU2275906C2 (ru) 2006-05-10
BR0102940A (pt) 2002-03-05
KR100759771B1 (ko) 2007-10-04
DE60123528D1 (de) 2006-11-16
EP1174131A1 (en) 2002-01-23
AU5446401A (en) 2002-01-24
KR20020007188A (ko) 2002-01-26

Similar Documents

Publication Publication Date Title
WO2001066564A3 (en) Gamma-secretase inhibitors
GB9801690D0 (en) Therapeutic agents
FI950309A (fi) Proliiniamidijohdannaisia
GB0225474D0 (en) Therapeutic agents
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
ATE248837T1 (de) Chinuclidin-acrylamide
BG106158A (en) New use of compounds as antibacterial agents
ES2166046T3 (es) Derivados de arilacrilamida como agonistas o antagonistas de 5ht1.
NO20013544D0 (no) Middel for å behandle Parkinsons sykdom samt anvendelse derav
NO20030639L (no) Piperidinderivater og legemidler inneholdende disse derivater som den aktive bestanddel
AU2003292006A1 (en) 3,5,3'-triiodothyronine sulfate as thyromimetic agent and pharmaceutical formulations thereof
ATE497764T1 (de) Perkutane absorptionszubereitungen mit 3-methyl-1-phenyl-2-pyrazolin-5-on
ATE250021T1 (de) Hydroxycyclopentanone
BRPI0010150B8 (pt) solução oral de prucalopride
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
DE69627519D1 (de) Sesquiterpen-derivate mit antiviraler aktivität
DK0629615T3 (da) Indolderivater som glutamatantagonister
DE60039782D1 (de) Amidinophenylbrenztraubensäure-derivat
EP1500656A4 (en) BIGUANIDE DERIVATIVE AND DIABETES TREATMENT AGENT CONTAINING
DE60026559D1 (de) Arzneimittel gegen essstörungen
DE69815347D1 (de) Tetrahydrofuranderivate
AU9235101A (en) Remedies for retinal nerve diseases containing 1,2-ethanediol derivatives or salts thereof
RU99102322A (ru) Средство для подавления роста сульфат-восстанавливающих бактерий

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application